BLOOD CANCER JOURNAL

Journal

Identifier:

E205920

ISSN:

2044-5385

Overview

Research Outputs (30)

A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells

Academic Article

A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis

Academic Article

Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study

Academic Article

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Academic Article

BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy.

Academic Article

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Academic Article

Breakthrough infections in MPN-COVID vaccinated patients

Academic Article

CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles

Academic Article

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Academic Article

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model

Academic Article

Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia(Blood Cancer Journal, 10.1038/s41408-025-01394-7)

Academic Article

Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.

Academic Article

Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

Academic Article

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

Academic Article

Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data

Academic Article

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score

Academic Article

LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

Academic Article

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

Academic Article

Long-term follow-up of recovered MPN patients with COVID-19

Academic Article

Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis

Academic Article

Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera

Academic Article

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with

Academic Article

Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients

Academic Article

Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia

Academic Article

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients

Academic Article

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

Academic Article

The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients

Academic Article

Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors

Academic Article

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

Academic Article

Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis

Academic Article

No Results Found

BLOOD CANCER JOURNAL

Overview

Research Outputs (30)